Roche Secures CE Mark For Cobas Smart E Immunoanalyser Using Same Reagents As High-Throughput Platforms, Enabling Smaller Labs To Bring Testing In-House

Benzinga · 5d ago
  • The cobas smart e immunoanalyser – the newest addition to Roche’s industry-leading cobas immunoassay systems portfolio – is engineered to deliver central-lab performance in a footprint under one square metre. 
  • With a planned menu of over 100 high-medical-value assays, and reaction times of 18 minutes or less for more than 90% of tests, the platform allows smaller laboratories to bring testing in-house, reducing turnaround times for patients.1,2,3
  • The cobas smart e uses the same reagents and Elecsys®  technology as Roche's high-throughput platforms, optimising patient management with consistent test results over time and across different locations.